Chondroxide tablets are a medicine designed to stimulate the regeneration of cartilage. This drug also has analgesic and anti-inflammatory effects.
Chondroxide tablets create the maximum concentration in plasma when administered once after 34 hours, and after 45 hours in the synovial fluid. It should be noted that this drug accumulates almost completely in the cartilage tissue, and for its penetration into the articular cavity, the synovial membrane is not an obstacle. Throughout the day, it is excreted with the help of the kidneys.
Chondroxide tablets contain 0.25 grams of dry matter of chondroitin sulfate (active ingredient), as well as auxiliary substances - calcium stearate, crospovidone, polyvinylpyrrolidone (povidone), MCC, as well as a sufficient amount of basic carbonic water magnesium (magnesium carbonate).
This drug provides a basis for bone and cartilage tissue, also affects the metabolic processes in the fibrous and hyaline cartilage. In addition, Chondroxide tablets inhibit the destruction of connective and cartilage tissues, inhibiting enzymes that affect cartilage tissue.
Obstruction of compression of the connective tissue and a peculiar lubrication of the surfaces of the joint - all this is provided by Chondroxide. Pills reviews are positive, since they also stimulate the synthesis of glycosaminoglycans, and increase the production of intraarticular fluid, and ensure the regeneration of cartilaginous articular surfaces and the joint bag, which reduces inflammation, increases the mobility of joints altered by the pathological process, and also reduces pain when walking and even peace.
It has potential properties that prevent the formation of blood clots from fibrin in the subchondral and synovial microvasculature. An important property is the slowdown in its application of the progression of osteochondrosis and osteoarthrosis. When using Chondroxide, the metabolism in the articular cartilage is normalized, which also stimulates its regeneration. A characteristic feature of this drug is the preservation of the achieved therapeutic effect for a long time after the end of its use.
"Chondroxide" is indicated for use in the development of degenerative diseases of the spine and joints, including osteochondrosis and osteoarthritis of the spine (both for prevention and treatment).
Contraindications to its use are the following conditions:
- Pregnancy period
- Lactation
- The presence of hypersensitivity to any component of this drug.
Caution should be given to patients with a history of bleeding and a tendency to bleed.
During pregnancy, its use is strictly contraindicated. During lactation, during the course of therapy, it is necessary to stop breastfeeding.
When using "Chondroxide" may develop allergic reactions, nausea, diarrhea. If an allergy occurs, “Chondroxide” must be canceled.
Instruction manual
Tablets must be taken orally, washed down with a small amount of liquid. 2 times a day at 0.5 grams. The duration of the initial course of its application should be six months. After discontinuation of Chondroxide, its therapeutic effect persists for about 3 years (depending on the stage of the disease and its location). If necessary, you can conduct repeated courses, their duration is determined individually.
Please note, this drug can enhance the pharmacological effect of fibrinolytics, anticoagulants and antiplatelet agents.